Therapeutic and Diagnostic Applications Based on the Role of the CXCR-4 Gene in Tumorigenesis

Details for Australian Patent Application No. 2004200560 (hide)

Owner Northwest Biotherapeutics, Inc.

Inventors Sehgal, Anil; Murphy, Gerald P.; Boynton, Alton L.

Agent Spruson & Ferguson

Pub. Number AU-B-2004200560

Parent 766675

Filing date 12 February 2004

Wipo publication date 11 March 2004

Acceptance publication date 20 September 2007

International Classifications

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

A61K 31/711 (2006.01) - Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 35/00 (2006.01) Antineoplastic agents

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07K 14/715 (2006.01) Peptides having more than 20 amino acids

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/32 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

4 March 2004 Complete Application Filed

11 March 2004 Application Open to Public Inspection

  Published as AU-B-2004200560

22 April 2004 Section 223 Application Allowed

  Northwest Biotherapeutics, Inc. The time in which to make a further application for a divisional patent has been extended to 23 Feb 2004. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000

20 September 2007 Application Accepted

  Published as AU-B-2004200560

17 January 2008 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 25 Sep 2007. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000

24 January 2008 Standard Patent Sealed

25 October 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004200561-A method and apparatus for emitting a signal

2004200559-A Tray and Blank Therefor (Flexo Tray)